Impact of National Centralized Drug Procurement Policy on Antiviral Utilization and Expenditure for Hepatitis B in China

BACKGROUND AND AIMS: The National Centralized Drug Procurement (NCDP) policy was launched in mainland China in April 2019, with entecavir (ETV) and tenofovir disoproxil fumarate (TDF) being included in the procurement list. We conducted the current study to investigate the impact of the NCDP policy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xinyu, Li, Min, Wang, Hao, Xu, Xiaoqian, Wu, Xiaoning, Sun, Yameng, Ning, Canjian, Wang, Bingqiong, Chen, Shuyan, You, Hong, Jia, Jidong, Kong, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240235/
https://www.ncbi.nlm.nih.gov/pubmed/35836769
http://dx.doi.org/10.14218/JCTH.2022.00167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240235/
https://www.ncbi.nlm.nih.gov/pubmed/35836769
http://dx.doi.org/10.14218/JCTH.2022.00167

Ejemplares similares